Mologic achieves breakthrough in ultra-sensitive point-of-care diagnostics and develops new platform technology

By |2021-05-20T11:25:16+01:00May 7th, 2019|

Visually-read device delivers up to 1,000-fold improvement in sensitivity to support surveillance and elimination efforts of global epidemics Since 2016, the Bill & Melinda Gates Foundation has committed $9.7 million to establish and accelerate the CARD technology programme Bedfordshire, UK, 7 May 2019: Mologic Ltd, a leading developer of [...]

Mologic expands US and UK operations

By |2021-05-20T11:30:12+01:00April 1st, 2019|

Strengthens team as part of continued international expansion Bolsters US presence with the opening of subsidiary in Boston, MA Doubles device manufacturing capacity in UK Bedfordshire, UK, 1 April 2019: Mologic Ltd, a leading developer of lateral flow and rapid diagnostic technologies, services and products, today announced it [...]


By |2021-05-20T11:29:16+01:00March 14th, 2019|

Today the Foundation for Innovative New Diagnostics (FIND) is leading a consortium, of which Mologic is part, announced the launch of a new schistosomiasis programme within its neglected tropical disease portfolio. FIND is leading a consortium which along with the WHO is developing novel rapid diagnostic tests for schistosomiasis infection that affects over 206 million people across 78 tropical and sub-tropical countries

Developing In-Home Respiratory, Professional-Use Sepsis Diagnostics for US Launch

By |2021-05-20T11:27:46+01:00October 8th, 2018|

In a recent interview with 360Dx, Mark Davis discussed how Mologic continues to develop it’s strong pipeline of rapid POC diagnostics and begins to look into the North American market for expansion and strategic partners... NEW YORK (360Dx) – Mologic is expanding into the US market and targeting the near-term commercialization of rapid [...]


By |2021-05-13T10:40:20+01:00August 2nd, 2018|

Bedfordshire, UK, 02 August 2018: Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has commenced a clinical trial to evaluate the Company’s urine-based diagnostic, HeadsUp, in monitoring pulmonary exacerbation in cystic fibrosis (CF) patients. The study aims to identify [...]


By |2021-05-18T13:55:29+01:00August 1st, 2018|

The Foundation for Innovative New Diagnostics (FIND) announced last Friday that it has awarded grants to a number of companies to address the urgent diagnostic needs for hepatitis C virus (HCV). These grants will be used to conduct feasibility studies of various technologies that could transform HCV testing at [...]

US FDA approved Krintafel (tafenoquine) for the radical cure of P.vivax in malaria

By |2021-05-18T13:51:05+01:00July 23rd, 2018|

GSK and Medicines for Malaria Venture (MMV) today announced that the United States Food and Drug Administration (FDA) has approved, under Priority Review, single-dose Krintafel(tafenoquine) for the radical cure (prevention of relapse) of Plasmodium vivax (P. vivax) malaria in patients aged 16 years and older who are receiving appropriate antimalarial therapy for acute P. vivax infection. [...]

Mologic and Newcastle University launch BReD

By |2018-11-29T09:34:53+00:00June 12th, 2018|

Mologic and Newcastle University launch BReD diagnostic for blackgrass resistance at Cereals Bedfordshire and Newcastle, UK, 13 June 2018: Mologic Ltd, a developer of personalised diagnostics, and Newcastle University, today announced they have developed an on-farm blackgrass resistance diagnostic (BReD). The one-step, rapid lateral flow product for detecting glutathione transferase (AmGSTF1) [...]

Mologic signs agreements with Medisur and Peripal

By |2018-11-29T09:34:53+00:00May 1st, 2018|

Mologic Signs Agreements with Medisur and Peripal to Distribute PERIPLEX POC Diagnostic in Europe Bedfordshire, UK, 1st May 2018: Mologic Ltd, a developer of powerful, personalised diagnostics to improve the lives of patients, today announced that it has signed agreements with medical technology companies, Medisur and Peripal AG to distribute PERiPLEX®, a rapid point-of-care (POC) [...]

PATH and Mologic advance new malaria test

By |2018-11-29T09:34:53+00:00April 18th, 2018|

Test will expand the range of diagnostic options available to guide treatment of Plasmodium Vivax Seattle, Washington, April 17, 2018—PATH and United Kingdom-based test developer Mologic have entered an agreement to advance a new rapid diagnostic test to support treatment and elimination of Plasmodium vivax, or relapsing, malaria. “This test will be a [...]

Vacancy for Quality Systems Administrator – Thurleigh

By |2018-11-29T09:34:53+00:00April 4th, 2018|

QUALITY SYSTEM ADMINISTRATOR MOLOGIC LTD IS SEEKING A QUALITY SYSTEM ADMINISTRATOR TO WORK WITH ITS IVD MEDICAL DEVICES DEVELOPMENT AND MANUFACTURING PROGRAMMES. Responsibilities and Duties. The role is based at Mologic Ltd (Thurleigh), an innovative healthcare diagnostics company. You will work with and report directly to the Quality & Regulatory [...]

Our interview with Technology Networks

By |2020-05-07T09:31:41+01:00March 29th, 2018|

Barbara Fallowfield, Commercial Manager of Mologic was recently interviewed by Anna Macdonald of Technology Networks where they discussed issues clinicians face whilst under pressure to prescribe antibiotics, and how a recent partnership between Fraunhofer UK, and Mologic can help tackle those issues through the development of a novel in vitro diagnostic assay. This assay [...]

Go to Top